The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Inhibitor-resistant TEM -lactamases: phenotypic, genetic and biochemical characteristics
Abstract
Beta-lactamases represent the main mechanism of bacterial resistance to beta-lactam antibiotics. The recent emergence of bacterial strains producing inhibitor-resistant TEM (IRT) enzymes could be related to the frequent use of beta-lactamase inhibitors such as clavulanic acid, sulbactam and tazobactam in hospitals and in general practice. The IRT beta-lactamases differ from the parental enzymes TEM-1 or TEM-2 by one, two or three amino acid substitutions at different locations. This paper reviews the phenotypic, genetic and biochemical characteristics of IRT beta-lactamases in an attempt to shed light on the pressures that have contributed to their emergence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Compilation and analysis of Escherichia coli promoter DNA sequences
Hawley, D. K., & McClure, W. R. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.8.2237 · Cited by 2,204
A standard numbering scheme for the class A β-lactamases
Ambler, R. P., Coulson, A. F. W., Frère, J. M., Ghuysen, J. M., Joris, B., Forsman, M., Levesque, R. C., Tiraby, G., & Waley, S. G. (1991) · Biochemical Journal · doi:10.1042/bj2760269 · Cited by 1,073
Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322.
Sutcliffe, J. G. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.8.3737 · Cited by 782
[Antibiogram Committee of the French Society for Microbiology. Official Statement 1999].
Soussy, C. (1999) · PubMed · Cited by 677
Molecular structure of the acyl-enzyme intermediate in β-lactam hydrolysis at 1.7 Å resolution
Strynadka, N. C. J., Adachi, H., Jensen, S. E., Johns, K., Sielecki, A., Betzel, C., Sutoh, K., & James, M. N. G. (1992) · Nature · doi:10.1038/359700a0 · Cited by 525
Catalytic properties of class A β-lactamases: efficiency and diversity
MATAGNE, A., LAMOTTE-BRASSEUR, J., & FRÈRE, J.-M. (1998) · Biochemical Journal · doi:10.1042/bj3300581 · Cited by 364
Crystal structure of Escherichia coli TEM1 β‐lactamase at 1.8 Å resolution
Jelsch, C., Mourey, L., Masson, J., & Samama, J. (1993) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340160406 · Cited by 357
Knox, J. R. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.12.2593 · Cited by 311
Kinetic interactions of tazobactam with beta-lactamases from all major structural classes
Bush, K., Macalintal, C., Rasmussen, B. A., Lee, V. J., & Yang, Y. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.4.851 · Cited by 274
Refined crystal structure of β-lactamase from Staphylococcus aureus PC1 at 2.0 Å resolution
Herzberg, O. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90527-d · Cited by 218
Bois, S. K. D., Marriott, M. S., & Amyes, S. G. B. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/35.1.7 · Cited by 177
Payne, D. J., Cramp, R., Winstanley, D. J., & Knowles, D. J. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.4.767 · Cited by 171
A natural polymorphism in β-lactamase is a global suppressor
Huang, W., & Palzkill, T. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8801 · Cited by 152
Blázquez, J., Baquero, M.-R., Cantón, R., Alós, J.-I., & Baquero, F. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.10.2059 · Cited by 152
Stapleton, P. D., Wu, P. J., King, A., Shannon, K. P., French, G. L., & Phillips, I. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2478 · Cited by 149
Imtiaz, U., Billings, E. M., Knox, J. R., Manavathu, E. K., Lerner, S. A., & Mobashery, S. (1993) · Journal of the American Chemical Society · doi:10.1021/ja00064a003 · Cited by 138
Belaaouaj, A., Lapouméroulie, C., Caniça, M. M., Vedel, G., Névot, P., Krishnamoorthy, R., & Paul, G. (1994) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1994.tb07010.x · Cited by 123
Self-citationZhou, X. Y., Bordon, F., Sirot, D., Kitzis, M.-D., & Gutmann, L. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.5.1085 · Cited by 121
Self-citation(1993) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1993.tb06475.x · Cited by 116
Videl, G., Belaaouaj, A., Gilly, L., Labia, R., Philippon, A., Névot, P., & Paul, G. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/30.4.449 · Cited by 115
Self-citationHenquell, C., Chanal, C., Sirot, D., Labia, R., & Sirot, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.2.427 · Cited by 115
Self-citationElucidation of the role of arginine-224 in the turnover processes of class A .beta.-lactamases
Zafaralla, G. C., Manavathu, E. K., Lerner, S. A., & Mobashery, S. (1992) · Biochemistry · doi:10.1021/bi00130a016 · Cited by 114
Brown, R. P. A., Aplin, R. T., & Schofield, C. J. (1996) · Biochemistry · doi:10.1021/bi961044g · Cited by 111
Sirot, D., Recule, C., Chaibi, E. B., Bret, L., Croizé, J., Chanal, C., Labia, R., & Sirot, J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.6.1322 · Cited by 110
Self-citationInhibition of β-lactamase by clavulanate
Chen, C. C. H., & Herzberg, O. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90472-v · Cited by 105
Emergence of an inhibitor-resistant beta-lactamase (SHV-10) derived from an SHV-5 variant
Prinarakis, E. E., Miriagou, V., Tzelepi, Ε., Gazouli, M., & TZOUVELEKIS, L. S. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.4.838 · Cited by 105
Delaire, M., Labia, R., Samama, J., & Masson, J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36729-8 · Cited by 97
Self-citationFactors determining resistance to β-lactam combined with β-lactamase inhibitors in Escherichia coli
Reguera, J. A., Baquero, F., Pérez-Díaz, J. C., & Martínez, J. L. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/27.5.569 · Cited by 97
TEM1 β-lactamase structure solved by molecular replacement and refined structure of the S235A mutant
Fonzé, E., Charlier, P., To'th, Y., Vermeire, M., Raquet, X., Dubus, A., & Frère, J. (1995) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994014496 · Cited by 85
A Structure-Based Analysis of the Inhibition of Class A .beta.-Lactamases by Sulbactam
Imtiaz, U., Billings, E. M., Knox, J. R., & Mobashery, S. (1994) · Biochemistry · doi:10.1021/bi00185a009 · Cited by 83
Wu, P. J., Shannon, K. P., & Phillips, I. R. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.3.494 · Cited by 71
Henquell, C., Sirot, D., Chanal, C., de Champs, C., Chatron, P., Lafeuille, B., Texier, P., Sirof, J., & Cluzel, R. A. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/34.5.707 · Cited by 65
Self-citationLemozy, J., Sirot, D., Chanal, C., Huc, C., Labia, R., Dabernat, H., & Sirot, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2580 · Cited by 60
Self-citationTRC-1: Emergence of a clavulanic acid-resistant TEM β-lactamase in a clinical strain
Thomson, C. J. (1992) · FEMS Microbiology Letters · doi:10.1016/0378-1097(92)90669-f · Cited by 57
Mechanism of turnover of imipenem by the TEM .beta.-lactamase revisited
Taibi, P., & Mobashery, S. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00134a003 · Cited by 55
Small plasmids are involved in amoxicillin-clavulanate resistance in Escherichia coli
Martínez, J. L., Vicente, M. F., Delgado‐Iribarren, A., Pérez-Díaz, J. C., & Baquero, F. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.4.595-a · Cited by 54
Bret, L., Chanal, C., Sirot, D., Labia, R., & Sirot, J. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/38.2.183 · Cited by 54
Self-citationFarzaneh, S., Chaibi, E. B., Péduzzi, J., Barthélémy, M., Labia, R., Blázquez, J., & Baquero, F. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2434 · Cited by 48
Self-citationTazobactam is a potent inactivator of selected inhibitor-resistant class A β-lactamases
Bonomo, R. A., Rudin, S., & Shlaes, D. M. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1997.tb10267.x · Cited by 44
Zafaralla, G. C., & Mobashery, S. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00030a070 · Cited by 43
Péduzzi, J., Reynaud, A., Baron, P., Barthélémy, M., & Labia, R. (1994) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(94)90048-5 · Cited by 41
Self-citationMechanisms of hyperproduction of TEM-1 β-lactamase by clinical isolates of Escherichia coli
Wu, P., Shannon, K. P., & Phillips, I. R. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/36.6.927 · Cited by 41
Saves, I., Burlet‐Schiltz, O., Swarén, P., Lefévre, F., Masson, J., Promé, J., & Samama, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.31.18240 · Cited by 40
Tazobactam is a potent inactivator of selected inhibitor-resistant class A β-lactamases
Bonomo, R. A. (1997) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(97)00013-x · Cited by 40
Clinical inhibitor-resistant mutants of the β-lactamase TEM-1 at amino-acid position 69
Chaibi, E. B., Péduzzi, J., Farzaneh, S., Barthélémy, M., Sirot, D., & Labia, R. (1998) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(97)00127-1 · Cited by 39
Self-citationOHIO-1 β-lactamase resistant to mechanism-based inactivators
Bonomo, R. A. (1992) · FEMS Microbiology Letters · doi:10.1016/0378-1097(92)90545-y · Cited by 34
Chardon, H., Farzaneh, S., Labia, R., Jarlier, V., Nicolas-Chanoine, M.-H., PAUL, G., Poyart, C., Sirot, D., & Sirot, J. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/36.1.267 · Cited by 16
Self-citationBémer-Melchior, P., Gilly, L., Jugroot-Klotz, K., et al. (1995) · PubMed · Cited by 12
Chaibi, E. B., Farzaneh, S., Morand, A., Péduzzi, J., Barthélémy, M., Sirot, D., & Labia, R. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/37.1.190 · Cited by 8
Self-citation
Cited by
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Bradford, P. A. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.933-951.2001 · Cited by 2,618
Three Decades of β-Lactamase Inhibitors
Drawz, S. M., & Bonomo, R. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00037-09 · Cited by 1,709
Growing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes
Bonnet, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.1-14.2004 · Cited by 1,494
Synergism between natural products and antibiotics against infectious diseases
Hemaiswarya, S., Kruthiventi, A. K., & Doble, M. (2008) · Phytomedicine · doi:10.1016/j.phymed.2008.06.008 · Cited by 916
Metadata
- Authors
- Chaibi, E. B., Sirot, D., Paul, G., & Labia, R.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-04-01
- Volume
- 43
- Issue
- 4
- Pages
- 447-458
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2163823303
- Cited by
- 256
- References
- 49
- FWCI
- 7.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.